Skip to content

A Comparative Study Of Nefopam-Dexamethasone And Pethidine-Dexamethasone For Post Caesarean Section Pain Management

Pain Management in Post-Caesarean Sections: Nefopam vs. Pethidine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202309805784870
Enrollment
144
Registered
2023-09-13
Start date
2020-08-05
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Cesearean setion pain Anaesthesia

Interventions

Nefopam combined with Dexamethasone

Sponsors

Self
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? All ASA II and III patients at term gestation for elective Caesarean section under subarachnoid block. ASA II and III are contradictions to what are labelled as exclusion criteria (PUD, DM and uncontrolled hypertension) .

Exclusion criteria

Exclusion criteria: ? Patient’s refusal to give written informed consent. ? Patients with known allergy or sensitivity to the study medication ? Present or past history of peptic ulcer disease ? Contraindications to spinal anaesthesia ? Diabetes mellitus Type 1 or 2 ? Systemic infection, ? Patients with coexisting hepatic, renal, or cardiovascular disease. ? History of chronic pain. ? Opioid use 48hours preceding surgery. ? Antenatal diagnosis of foetal abnormality ? Known IV drug users. ? Glaucoma ? Liver cirrhosis ? Psychiatric illnesses ? Patients on antiviral medications or live vaccines ? Uncontrolled hypertension ? Requiring more than 100mg IV Tramadol for treatment of breakthrough pain

Design outcomes

Primary

MeasureTime frame
The primary outcome for the study was the proportion of patients scoring less than or equal to 3 using the NRS, at 6 and 12 hours after the administration of study drugs

Secondary

MeasureTime frame
a) Time to first analgesic request. The time from administration of study drugs to first analgesic request. b) Comparison of pain scores between the two groups in the first 24 hours postoperatively. c) Comparison of the Total analgesic consumption between the two groups in the first 24 hours postoperatively d) Comparison of Incidences of side effects related to study drugs such as nausea and vomiting and sedation

Countries

Nigeria

Contacts

Public ContactChristian Igibah

Research Assistant at Department of Anaesthesia Irrua specialist teaching hospital

igibah@cancad.org08100267252

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026